/ Jul 9, 2015

Progress reported in using gene therapy for deafness

Gene therapy for deafness is moving closer to reality, with new research on Wednesday showing the technique for fixing faulty DNA can improve responses in mice with genetic hearing loss. Separately, a clinical trial backed by Novartis is under way to help a different group ...

Diovan scandal traced to cozy doctor-drugmaker ties

Feb 27, 2014

Diovan scandal traced to cozy doctor-drugmaker ties

The manipulation of clinical research data used to develop the blood pressure drug Diovan sold by Novartis Pharma K.K. has prompted a special squad of Tokyo prosecutors to search the Japanese unit of the Swiss drugmaker as well as the universities that conducted the ...

Feb 19, 2014

Tokyo prosecutors raid Novartis Pharma over drug ads

Tokyo prosecutors raided Novartis Pharma K.K. on Wednesday over its alleged use of exaggerated advertising for a blood pressure-lowering drug, following a criminal complaint filed by the health ministry last month. The ministry claimed that the ads for Diovan cited clinical study reports by two ...

Novartis drug data meddling clouds Japan's clinical studies

Oct 3, 2013

Novartis drug data meddling clouds Japan's clinical studies

A health ministry panel is questioning Novartis Pharma K.K.'s use of clinical research data in promoting the sale of Diovan, its drug to lower blood pressure, saying it "could constitute misleading advertisement" after revelations that some of the data were manipulated. The Japanese unit of ...

Jul 28, 2013

Question of objectivity

A Kyoto university's announcement that research on blood-pressure drug Diovan was manipulated raises concerns about the drugmaker's objectivity.